Stockreport

LivaNova Permitted to Modify Cardiopulmonary Products' Indications for Use to Include ECMO Therapy Beyond Six Hours to Address COVID-19

LivaNova PLC - Ordinary Shares  (LIVN) 
Last livanova plc - ordinary shares earnings: 4/29 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: livanova.com
PDF Various products can now be used to treat patients experiencing acute respiratory or cardiopulmonary failure LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a ma [Read more]